Background: Staphylococcus aureus (S. aureus) is frequently detected in the skin of
The skin surface consists of a horny layer derived from keratinocytes, which recognize S. aureus by sensing receptors, such as Toll-like receptors (TLRs). They induce pro-inflammatory cytokines and antibiotic peptides to combat and eliminate S. aureus, by activating skin immune cells. S. aureus, including its exotoxins and surface proteins, can initiate the production of pro-inflammatory cytokines such as thymic stromal lymphopoietin from keratinocytes, and stimulate mast cell degranulation, resulting in the skewing of T helper 2 cells. [7] [8] [9] Thus, S. aureus colonization can contribute to chronic skin inflammation in AD. However, the role of S. aureus strains isolated from AD skin (S. aureus-AD) may vary depending upon the strains. It is noteworthy that S. aureus strains carrying the gene for Panton-Valentine leucocidin, but not those without this gene, cause highly lethal pneumonia. 10 Moreover, several studies have shown correlations between the severity of AD and the presence of S. aureus that produces super-antigen on AD skin. 11 These findings suggest that, not only the abundance of S. aureus but also a certain types of S. aureus strains could influence AD. In fact, our previous study demonstrated that S. aureus-AD activate human Langerhans cells (LCs) and induce Th2-prone T-cell proliferation significantly more than strains of standard S. aureus (S. aureus-stand.).
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In this study, we analyzed innate immune responses of keratinocytes in response to various strains of staphylococcus to verify the role of S. aureus-AD in the development and/or aggravation of dermatitis observed in AD.
| MATERIALS AND METHODS
All experiments were performed in compliance with ethical guidelines for academic research in hiroshima university.
| Preparation of S. aureus and S. epidermidis
Eight strains of S. aureus TF3378, TF2962, TF2870, TF2868, NCTC8325, Mu50, FDA209P, and Newman and one strain of S. epidermidis ATCC12228 were used in this study. S. aureus TF3378, TF2962, TF2870, and TF2868 were clinically isolated from lesional skin surface of different patients with AD, and retained different sequential types as described in Table S1 . S. aureus NCTC8325, Mu50, FDA209P, and Newman were laboratory control strains and used as control for clinical isolates. NCTC8325
was isolated from a sepsis patient. 13 Mu50 was isolated from the purulent discharge at the sternal incision site. 14 The origin of FDA209P is unknown, but used as drug-naive standard S. aureus.
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Newman was isolated from a case of secondarily infected tubercular osteomyelitis in man. 16 All strains preserve genes for fibronectin-binding proteins (FnBPs). Newman was shown to harbor mutation in FnBPs. 17 They were grown in Tryptic soy broth (TSB) (Becton Dickinson, San Diego, California) at 37°C for 24 hour with shaking and washed twice by phosphate-buffered saline (PBS). The amounts of
G R A P H I C A L A B S T R A C T
Compared to standard S. aureus strains, S. aureus isolated from AD skin are able to induce different innate immune responses. S. aureus from AD skin are internalized into keratinocytes and accumulate in lysosomes with inducing IL-1α secretion via TLR9. Specific surface proteins of S. aureus from AD skin are responsible for their internalization.
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| 561 bacterial stimuli were adjusted by Optical Density (OD) at 660 nm to 1.0 followed by calculations of their colony-forming units (CFU). S. aureus strains and S. epidermidis were heat-killed by incubation at 57°C for 1 hour and treated with proteinase K as described previously. 
| Flow cytometry
The FITC intensity of green stained lysosomes of 
| SDS-PAGE, western ligand affinity assay, and Western blotting
Cell wall-associated proteins were obtained as described previously 12 and separated by sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using a 5%-20% acrylamide gradient (Bio-Rad). Proteins were (Table S1 ).
| Statistical analysis
We then quantified inflammatory and itch-inducing cytokines in the culture supernatants 72 hour after stimulation with S. aureus or S. epidermidis. Three out of four S. aureus-AD strains (TF3378, TF2962, and TF2868) induced a high amount of IL-1α secretion compared to those by S. aureus-stand. or S. epidermidis ( Figure 1A , S1A). Two S. aureus-AD strains (TF3378 and TF2962) also induced high amounts of GM-CSF ( Figure 1B ), but no difference was seen in the production of IL-6 ( Figure 1C , S1B). The amounts of IL-1β, TNF-α, IL-31, and IL-33
were under detection limit (data not shown). IL-1α accumulated in a time-dependent manner ( Figure S2 ), and low dose of S. aureus-AD strain (TF3378) could not induce cytokine secretion ( Figure S3A ).
We assessed the proliferation of HaCaT cells using MTS assay, but no difference was observed among all S. aureus strains and S. epidermidis ( Figure 1D ). These results revealed that heat-killed S. aureus-AD (TF3378, TF2962, and TF2868) induced significantly high amounts of IL-1α secretion from HaCaT cells without cytotoxicity.
3.2 | Heat-killed S. aureus isolated from patients with AD was internalized into keratinocytes and accumulates in lysosome Figure 3A , S1D, S6, and S7).
FACS analysis also showed a substantial amount of lysosome green population in HaCaT cells incubated with the three strains ( Figure 3B , 3C S1E). Mu50  FDA209P  ATCC12228  TF3378  TF2962  TF2868  TF2870   0   500   1000   1500   2000   2500   PBS  NCTC8325  Mu50  FDA209P  ATCC12228  TF3378  TF2962  TF2868  TF2870   0   10   20   30   40   50   60   70   80   PBS  NCTC8325  Mu50  FDA209P  ATCC12228  TF3378  TF2962  TF2868  TF2870 AD strains 
S. epi
Stand. strains S. epi Stand. strains
| S. aureus-AD induce IL-1α production via TLR9 pathway
To investigate the mechanism of IL-1α induction by S. aureus-AD, we studied the involvement of TLR9, which is expressed in endosomes and lysosomes, and recognizes CpG DNA of bacteria including S. aureus. The increase of IL-1α secretion in the culture supernatant of
HaCaT cells with strains of S. aureus-AD for 72 hour was decreased by the pretreatment with iODNs, a TLR9 antagonist 20 ( Figure 4A ). In contrast, the release of IL-6 induced by all strains of S. aureus strains and S. epidermidis was not affected by the treatment of iODNs ( Figure 4B ). In line with the inhibition by iODNs, the induction of IL-1α was canceled in TLR9 knockdown HaCaT cells ( Figure 4C ).
TLR2 is known to be the responsible receptor against S. aureus, and we tested whether TLR2 is involved with these responses. TLR2
knockdown did not affect the phenomenon induced by S. aureus-AD (TF3378) ( Figure S8 ).
| Phagocytosis and internalization of S. aureus-

AD by HaCaT cells depend on surface Protein of S. aureus-AD
To investigate the role of cell surface structures of heat-killed S. aureus-AD, we treated S. aureus TF3378 with proteinase K, which removes cell surface proteins, followed by washing and then exposure to HaCaT cells. S. aureus TF3378 treated with proteinase K significantly impaired the induction of IL-1α ( Figure 5A ). On the other hand, no effect was observed on IL-6 production ( Figure 5B ).
Immunohistochemical analysis showed that S. aureus TF3378 treated with proteinase K neither entered the cytoplasm nor accumulated in lysosomes ( Figures 5C and 5D which is also known to be involved in the phagocytosis of S. aureus by keratinocytes (data not shown).
To confirm the necessity of FnBP for the S. aureus-AD internalization, we blocked fibronectin by using an antibody against fibronectin. 22 The uptake of S. aureus-AD by HaCaT cells was partially inhibited by pre-treatment with a fibronectin antiserum. Mu50  FDA209P  ATCC12228  TF3378  TF2962  TF2868  TF2870   0   50   100   150   200   250   PBS  NCTC8325  Mu50  FDA209P  ATCC12228  TF3378  TF2962  TF2868  TF2870 : The keratinocyte layer is the first barrier in the skin against S. aureus and recognizes S. aureus by sensing receptors such as TLRs.
They produce pro-inflammatory cytokines and antibiotic peptides to eliminate S. aureus by activating immune cells in the skin. 23 IL-α, an IL-1 family member, activates the MyD88-dependent pathway resulting in various inflammatory responses. 24 Keratinocytes store IL-1α in their cytoplasm under resting conditions and release matured IL-1α in response to stimuli by pathogens including S. aureus. 25 The production of IL-1α is tightly controlled in healthy subjects 26 but increased in the skin of patients with AD who have the FLG gene mutation as compared to that in the skin of healthy individuals. Among the pattern recognizing receptors, TLR2 expressed on cell surface is known to be responsible for the host defense against S. aureus. 29 Moreover, polymorphisms in TLR2 are reported to be associated with the severity of AD 30 and function of TLR2 is downregulated in AD skin. 31 Furthermore, lipoproteins of S. aureus are known to induce IL-6 production in keratinocytes via the TLR1/TLR2
pathway. 32 On the other hand, TLR9 is typically located within endosomes and lysosomes, and recognizes CpG DNA of bacteria. 33 Keratinocytes also express TLR9, mostly in the upper layers of the stratum corneum of human skin, and therefore may recognize CpG oligonucleotide (TLR9 ligand). 34 It has been reported that certain strains of S. aureus are internalized by macrophages and then accumulate in lysosomes. 35 Dendritic cells may also incorporate specific strains of S. aureus and induce cytokines via TLR9. 36 Moreover, S. aureus may also be internalized by various non-phagocytic human cells including keratinocytes, as well. 37 Furthermore, polymorphisms in the TLR9 promoter with significantly higher activity are associated with the development of AD. 38 Thus, it is feasible that certain strains of S. aureus are selectively associated with, and internalized by keratinocytes of patients with AD. The mechanism of specific internalization by S. aureus-AD remains a matter of discussion. The abolishment of S. aureus internalization and IL-1α secretion by S. aureus-AD strains by the treatment with protease K and wortmannin suggests the involvement of bacterial surface proteins specific to S. aureus-AD, rather than exotoxins, and the PI3K pathway of keratinocytes in their internalization and IL-1α induction.
Among the surface proteins of S. aureus, FnBPs and Eap are known to induce phagocytosis and internalization of S. aureus by human cells including keratinocytes. 39, 40 FnBPs were shown to be involved in the adhesion of S. aureus to AD skin, 41 interacting with human α5β1integrins via fibronectin. 22 Furthermore, the expression level of FnBPs by S. aureus is known to vary among strains. 42 In this study, we have demonstrated that the expressions of FnBPs in three S. aureus-AD strains were larger than those in the other strain of S. aureus-AD and the strains of S. aureus-stand., which are not inter- Several trials, such as bleach baths, to improve AD by combatting S. aureus on AD skin have been reported. 43, 44 However, the colonization of S. aureus in patients with AD typically relapses a few weeks after such treatment. 45 Surface structures, which are specific to S. aureus strains isolated from patients with AD, may represent a new targeted approach to remove pathogenic S. aureus-AD with minimum disturbance of the physiological microbiome but with longlasting efficiency.
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